🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 111 of 200 · A–Z by INN

  1. lisdexamfetamine

    VYVANSE Lacuna Pharma Pty Ltd

    TGA: approved

  2. lisdexamfetamine dimesylate

    LISDEXAMFETAMINE DIMESYLATE ELITE PHARMACEUTICALS INC /NV/

    ORAL FDA: approved

  3. lisinopril

    APO-LISINOPRIL Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  4. lisocabtagene maraleucel

    BREYANZI

    EMA: approved

    L01XL08

  5. lisuride

    NENAD

    EMA: application withdrawn

  6. lithium carbonate

    LITHICARB Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved

  7. lithium citrate

    LITHIUM CITRATE

    ORAL FDA: approved

  8. lixisenatide

    LYXUMIA

    SUBCUTANEOUS FDA: approved · EMA: withdrawn · PMDA: approved

    A10BJ03

  9. lm-

    NMPA: clinical trials

  10. lm101

    NMPA: clinical trials

  11. lodoxamide tromethamine

    ALOMIDE

    OPHTHALMIC FDA: approved

  12. lofexidine hydrochloride

    LOFEXIDINE HYDROCHLORIDE

    ORAL FDA: approved

  13. lomefloxacin hydrochloride

    MAXAQUIN

    ORAL FDA: approved

  14. lomitapide

    LOJUXTA

    EMA: approved

    C10AX12

  15. lomitapide mesylate

    JUXTAPID

    ORAL FDA: approved

  16. lomustine

    GLEOSTINE

    ORAL FDA: approved

  17. lonafarnib

    ZOKINVY

    ORAL FDA: approved · EMA: approved

  18. lonapegsomatropin

    SKYTROFA (PREVIOUSLY LONAPEGSOMATROPIN ASCENDIS PHARMA)

    EMA: approved

    H01AC09

  19. lonapegsomatropin-tcgd

    SKYTROFA

    INJECTION FDA: approved

  20. loncastuximab tesirine

    ZYNLONTA

    EMA: approved

    L01FX22

  21. loncastuximab tesirine-lpyl

    ZYNLONTA ADC Therapeutics SA

    INJECTION FDA: approved

  22. lonoctocog alfa

    AFSTYLA

    EMA: approved · PMDA: approved

    B02BD02

  23. loperamide

    GASTREX Lacuna Pharma Pty Ltd

    TGA: approved · NMPA: clinical trials

  24. loperamide hydrochloride

    LOPERAMIDE HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources